Science Press Releases
SEE OTHER BRANDS

Informing on science news in the world

Science Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Science Press Releases.

Press releases published on June 11, 2025

House of Doge Appoints Fintech Leaders as CEO and Chief Payments Officer to Lead Global Expansion into Payments

House of Doge Appoints Fintech Leaders as CEO and Chief Payments Officer to Lead Global Expansion into Payments

MIAMI, June 11, 2025 (GLOBE NEWSWIRE) -- House of Doge, the official corporate arm of the Dogecoin Foundation, today announced the appointment of Marco Margiotta as Chief Executive Officer and Ryan Deslippe as Chief Payments Officer. The two fintech …

Nano Dimension Strengthens Board with Technology and Growth Experts to Accelerate Global Manufacturing Platform Expansion

Nano Dimension Strengthens Board with Technology and Growth Experts to Accelerate Global Manufacturing Platform Expansion

Waltham, Massachusetts, June 11, 2025 (GLOBE NEWSWIRE) -- Nano Dimension Ltd. (Nasdaq: NNDM) (“Nano Dimension” or the “Company”), a leader in Digital Manufacturing solutions, has appointed two technology and growth experts, Andy Sriubas and Eileen Tanghal, …

June Market Trends Favor Pi, XRP & SOL – ALL4 Cloud Mining Positioned to Capitalize on Growth

June Market Trends Favor Pi, XRP & SOL – ALL4 Cloud Mining Positioned to Capitalize on Growth

Philadelphia, Pennsylvania, June 11, 2025 (GLOBE NEWSWIRE) -- As the price of Bitcoin surges to over $100,000, altcoins are growing in popularity, with projects like Pi Network, XRP, and Solana gaining attention, and ALL4 Mining cloud mining has also …

Chiesi Group Enters into Worldwide Licensing Agreement with Key2Brain AB to Advance Blood-Brain Barrier-Crossing Therapies for Lysosomal Storage Disorders

Chiesi Group Enters into Worldwide Licensing Agreement with Key2Brain AB to Advance Blood-Brain Barrier-Crossing Therapies for Lysosomal Storage Disorders

Collaboration will leverage Key2Brain’s technology to develop blood-brain barrier-crossing enzyme replacement therapies for lysosomal storage disorders Agreement is built on a partnership initiated 2022, supporting continued development led by positive in …

Alpha Liquid Terminal Launches ChatAnalyst Financial Analyst Agent

Alpha Liquid Terminal Launches ChatAnalyst Financial Analyst Agent

New York, NY, June 11, 2025 (GLOBE NEWSWIRE) -- Alpha Liquid Terminal has launched the best-in-class AI Agent Financial Analyst uniquely designed to unify financial research across multiple asset classes — from crypto and equities to FX and private markets …

Ocugen To Present at BIO International Convention 2025

Ocugen To Present at BIO International Convention 2025

MALVERN, Pa., June 11, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that the Company will present at the 2025 BIO International …

Rigetti Computing Completes $350 Million At-the-Market Equity Offering

Rigetti Computing Completes $350 Million At-the-Market Equity Offering

BERKELEY, Calif., June 11, 2025 (GLOBE NEWSWIRE) -- Rigetti Computing, Inc. (Nasdaq: RGTI) (“Rigetti” or the “Company”), a pioneer in full-stack quantum-classical computing, today announced that it has completed sales of $350 million gross proceeds of its …

BrainsWay Reports Positive Results from Multicenter Randomized Study of Accelerated Deep TMS for Major Depressive Disorder (MDD)

BrainsWay Reports Positive Results from Multicenter Randomized Study of Accelerated Deep TMS for Major Depressive Disorder (MDD)

BURLINGTON, Mass. and JERUSALEM, June 11, 2025 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ …

Juvena Therapeutics and Lilly Enter Research Collaboration Focused on Muscle Health

Juvena Therapeutics and Lilly Enter Research Collaboration Focused on Muscle Health

Research will leverage world’s first AI-enabled screening platform for mapping the therapeutic potential of secreted signaling proteins, developed by Juvena Collaboration aims to accelerate the discovery of treatments that help individuals maintain and …

LeddarTech Provides Corporate Update

LeddarTech Provides Corporate Update

QUEBEC CITY, Canada, June 11, 2025 (GLOBE NEWSWIRE) -- LeddarTech® Holdings Inc. (“LeddarTech” or the “Company”) (Nasdaq: LDTC), an AI-powered software company recognized for its innovation in advanced driver assistance systems (ADAS) and autonomous …

LeddarTech fait le point sur son entreprise

LeddarTech fait le point sur son entreprise

QUÉBEC, Canada, 11 juin 2025 (GLOBE NEWSWIRE) -- LeddarTech® Holdings Inc. (« LeddarTech » ou la « Société ») (NASDAQ : LDTC), une société de logiciels reposant sur l’IA reconnue pour son innovation dans les systèmes avancés d’aide à la conduite (systèmes …

Vaxart Reports Positive Clinical Data Demonstrating that its Second-Generation Vaccine Technology Produces Much Stronger Antibody Responses than its First-Generation Technology

Vaxart Reports Positive Clinical Data Demonstrating that its Second-Generation Vaccine Technology Produces Much Stronger Antibody Responses than its First-Generation Technology

- Second-generation norovirus constructs produce statistically significant increases in GI.1 and GII.4 norovirus blocking antibodies (141% and 94%, respectively) compared with first-generation constructs, supporting potential for improved protection …

NextGen Digital Files Preliminary Short Form Base Shelf Prospectus

NextGen Digital Files Preliminary Short Form Base Shelf Prospectus

Fredericton, New Brunswick, June 11, 2025 (GLOBE NEWSWIRE) -- NextGen Digital Platforms Inc. (CSE:NXT) (OTCQB:NXTDF) (FSE:Z12) (“NextGen” or the “Company”) is pleased to announce that it has filed a preliminary short form base shelf prospectus with the …

Bitdeer Announces May 2025 Production and Operations Update

Bitdeer Announces May 2025 Production and Operations Update

- Increased self-mining hashrate to 13.6 EH/s on continued deployment of SEALMINERs - Sold and shipped 1.6 EH/s of SEALMINER A2s to external customers SINGAPORE, June 11, 2025 (GLOBE NEWSWIRE) -- Bitdeer Technologies Group (NASDAQ: BTDR) (“Bitdeer” or the …

Memo Therapeutics AG Publishes Study in Frontiers in Pharmacology Demonstrating Therapeutic Antibody Transcytosis Across the Kidney Barrier After Intravenous Administration

Memo Therapeutics AG Publishes Study in Frontiers in Pharmacology Demonstrating Therapeutic Antibody Transcytosis Across the Kidney Barrier After Intravenous Administration

Results demonstrate that intravenously administered therapeutic IgG antibodies can be detected in urine, supporting the conclusion that these antibodies are capable of crossing the kidney endothelial barrier This proof-of-concept study provides compelling …

Kymeta definitiert Konenektivität neu mit bahnbrechender Multiband-Antenne

Kymeta definitiert Konenektivität neu mit bahnbrechender Multiband-Antenne

Kymeta schafft Multiband-Konnektivität mit vier gleichzeitigen Strahlen in Ku- und Ka-Band-Frequenzen über eine einzige Antennenöffnung Ein technologischer Quantensprung eröffnet neue Möglichkeiten für den Einsatz von KI in Bereichen wie Verteidigung, …

L’antenne multibande révolutionnaire de Kymeta redéfinit la connectivité

L’antenne multibande révolutionnaire de Kymeta redéfinit la connectivité

Kymeta assure une connectivité multibande grâce à quatre faisceaux simultanés en bandes Ku et Ka avec une seule ouverture d’antenne Les avancées technologiques en matière de connectivité ouvrent la voie au développement de l’IA dans les secteurs de la …

Pasithea Therapeutics Appoints Expert in ETS2-driven Inflammatory Disease to Scientific Advisory Board

Pasithea Therapeutics Appoints Expert in ETS2-driven Inflammatory Disease to Scientific Advisory Board

MIAMI, June 11, 2025 (GLOBE NEWSWIRE) -- Pasithea Therapeutics Corp. (NASDAQ: KTTA) (“Pasithea” or the “Company”), a clinical-stage biotechnology company developing PAS-004, a next-generation macrocyclic MEK inhibitor, today announced the appointment of Dr …

SailPoint Announces Fiscal First Quarter 2026 Results

SailPoint Announces Fiscal First Quarter 2026 Results

Grew ARR 30% year-over-year to $925 million Increased SaaS ARR 39% year-over-year to $574 million Expanded the number of customers with more than $1 million of ARR by 62% year-over-year AUSTIN, Texas, June 11, 2025 (GLOBE NEWSWIRE) -- SailPoint, Inc. ( …

Instil Bio Names John Maraganore, Ph.D., to Board Role Supporting the Advancement of PD-L1xVEGF Bispecific Antibody Program

Instil Bio Names John Maraganore, Ph.D., to Board Role Supporting the Advancement of PD-L1xVEGF Bispecific Antibody Program

DALLAS, June 11, 2025 (GLOBE NEWSWIRE) -- Instil Bio, Inc. (“Instil”) (NASDAQ: TIL), a clinical-stage biopharmaceutical company focused on developing a pipeline of novel therapies, today announced the addition of John Maraganore, Ph.D., to the Board of …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service